Julia Bonavitacola

Richard Allen, MD, PhD, FACS, professor at Baylor College of Medicine, reviewed the challenges of oculoplastic surgery in pediatric patients.

A review found that visual impairment is common in older adults with dementia and associated with negative effects.

A new study has found that adults who were vaccine hesitant were more likely to show a positive change in opinion when presented with an interactive risk ratio simulation.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent reports from the World Health Organization about COVID-19.

A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo.

A new study found that protection from the Omicron variant waned 6 months after the second dose of a COVID-19 vaccine in older patients.

An analysis of 112 infant deaths found that the contribution of genetic diseases to mortality was higher than previously known, and that treatments are available for 30% of the genetic diseases uncovered by the study.

The Advisory Committee on Immunization Practices released the update to the Recommended Adult Immunization Schedule for all US residents aged 19 years and older, which has been approved by the CDC and medical groups.

Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed the potential of a respiratory syncytial virus vaccine in children, as well as ongoing efforts to get childhood vaccination rates back on track.

Disparities in access to pediatric ophthalmological care is associated with lower socioeconomic status.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed treatment of respiratory syncytial virus (RSV) without a vaccine and what a future vaccine could mean for older adults.

A new study aimed to assess the quality and reliability of videos uploaded to YouTube that provide information around spinal muscular atrophy (SMA).

Vaccination rates against influenza and pneumococcus were lower in patients receiving organ transplants who lived outside of urban areas and had lower socioeconomic status.

A recent study has found that the prevalence of vision impairment in US adults 71 years and older was higher in 2021 compared with prior estimates.

Timothy Murphy, MD, FACP, practice president of Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the effect of the COVID-19 pandemic on screening for lung cancer.

Michael Chiang, MD, director of the National Eye Institute, spoke about efforts to address age-related macular degeneration (AMD) as well as health disparities in clinical trials and access to treatment.

Patients with spinal muscular atrophy (SMA) could have improved monitoring and assessment of their disease through the utilization of patient-reported outcome measures.

Retinal nerve fiber layer (RNFL) thickness has been independently associated with incident cardiovascular disease risks in a new analysis that utilized data from 2 international databases.

A new review found that messenger RNA (mRNA) vaccines were able to prevent COVID-19 infection and severe illness in children aged 5 to 11.

Timothy Murphy, MD, FACP, current practice president at Rocky Mountain Cancer Centers, spoke with The American Journal of Managed Care® about the current state of lung cancer screenings.

A study found that adherence to the CDC recommendation of mRNA monovalent COVID-19 boosters was low in immunocompromised individuals.

A perspective article discussed the possible approaches that scientists can take in developing a new generation of vaccines to fight against several respiratory viruses.

A study found that screening for spinal muscular atrophy (SMA) in newborns paired with early access to disease-modifying therapies was effective in alleviating the burden and comorbidities of the disease.

A new study has found that vaccine effectiveness against infection after 4 doses of the COVID-19 vaccine disappeared after 90 days for Omicron variants BA.2, BA.2.12.1, BA.4, and BA.5, although it remained effective against hospitalizations.

Patients who took hydroxychloroquine had an overall risk of hydroxychloroquine retinopathy of 8.6% after 15 years.

Depending on their COVID-19 vaccination status, there were differences in the sources first responders in Kentucky preferred to receive information from, their willingness to believe conspiracy theories, and the perceived risk of the virus.

Qualitative interviews conducted with caregivers of children with spinal muscular atrophy (SMA) found that the symptoms with the greatest effect on disease burden were not always the most prevalent symptoms in patients.

Retinal vasculature in peripheral regions of the retina differed in patients with Alzheimer dementia and mild cognitive impairment.

Diagnosing ocular surface diseases could be made easier as artificial intelligence (AI) screening improves.